| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novabridge Biosciences (NBP) has 1 insider with recent SEC Form 4 filings, including 0 buys and 1 sell. NBP is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 290.2K | $435.2K | -3,494 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Xu Cong Claire | SVP, Clinical Development | Sale+OE | 3,494 | $3.94 | $13,766.36 | -1.2% | - | - |